Welcome to LookChem.com Sign In|Join Free

CAS

  • or

320407-92-9

Post Buying Request

320407-92-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

320407-92-9 Usage

General Description

4-BROMOMETHYL-2-CHLORO-1-METHOXYBENZENE is a chemical compound with the molecular formula C8H8BrClO. It is a white crystalline solid that is used in the synthesis of various pharmaceuticals and agrochemicals. 4-BROMOMETHYL-2-CHLORO-1-METHOXYBENZENE is known for its potential as an intermediate in the production of many other chemicals and is used in organic synthesis processes. It is important to handle this compound with care as it is toxic and may cause irritation to the skin, eyes, and respiratory system. Additionally, it should be stored in a cool, dry place away from sources of heat and ignition.

Check Digit Verification of cas no

The CAS Registry Mumber 320407-92-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,0,4,0 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 320407-92:
(8*3)+(7*2)+(6*0)+(5*4)+(4*0)+(3*7)+(2*9)+(1*2)=99
99 % 10 = 9
So 320407-92-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H8BrClO/c1-11-8-3-2-6(5-9)4-7(8)10/h2-4H,5H2,1H3

320407-92-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Bromomethyl)-2-chloro-1-methoxybenzene

1.2 Other means of identification

Product number -
Other names 4-bromomethyl-2-chloro-anisole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:320407-92-9 SDS

320407-92-9Relevant articles and documents

CHEMICAL COMPOUNDS

-

Page/Page column 94-95, (2012/02/02)

The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein X, Ar1, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.

METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES

-

Page/Page column 37, (2010/11/25)

The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for

Indole derivatives as MCP-1 receptor antagonists

-

, (2008/06/13)

A compound of Formula I, wherein: R1 is hydrogen, halo, methyl, ethyl or methoxy; R2 is hydrogen, halo, methyl, ethyl or methoxy; R3 is a halo group, lower alkyl, lower alkenyl, lower alkynyl, alkoxy, trifluoromethyl, nitro, cyano, trifluoromethoxy, C(O)R7, or S(O)nR7 where n is 0, 1 or 2 and R7 is an alkyl group; R4 is a halo, trifluoromethyl, methylthio, methoxy, trifluoromethoxy or lower alkyl, lower alkenyl or lower alkynyl or COR8 where R8 is lower alkyl; R6 is hydrogen, halo, lower alkyl, lower alkenyl, lower alkynyl or COR9 where R9 is lower alkyl; provided that when R1 is hydrogen, halo or methoxy, R2 is hydrogen, halo, methyl, ethyl or methoxy, R5 and R6 are both hydrogen, and one of R3 or R4 is not halo or trifluoromethyl; or a pharmaceutically acceptable salt or prodrug thereof. These compounds have useful activity for the treatment of inflammatory disease, specifically in antagonizing an MCP-1 mediated effect in a warm-blooded animal such as a human being.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 320407-92-9